Thromboprophylaxis with apixaban and the risk of pulmonary embolism in patients undergoing knee replacement surgery

• Egile Nagusiak: Madan Raj Aryal (Egilea), Anil Pandit (Egilea), Sushil Ghimire (Egilea), Ranjan Pathak (Egilea), Paras Karmacharya (Egilea), Dilli Ram Poudel (Egilea), Fadi E. Shamoun (Egilea)
• Formatua: Liburua
• Argitaratua: Greater Baltimore Medical Center, 2015-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: Apixaban, a novel oral anticoagulant, is also used for deep vein thrombosis (DVT) prophylaxis. In this study, we sought to critically evaluate the differences in the rates of symptomatic DVT and bleeding, and analyze the rates of pulmonary embolism (PE) in subgroups of patients from ADVA...